Page last updated: 2024-11-05

pelargonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pelargonic acid, also known as nonanoic acid, is a saturated fatty acid with the chemical formula CH3(CH2)7COOH. It is a colorless liquid with a pungent odor. Pelargonic acid is found naturally in some plants and animal fats. It can be synthesized by oxidation of oleic acid. Pelargonic acid has been studied for its potential applications in various fields, including cosmetics, pharmaceuticals, and agriculture. In cosmetics, pelargonic acid is used as a fragrance ingredient. It has also been shown to have antimicrobial and antifungal properties, making it a potential ingredient in topical medications. In agriculture, pelargonic acid has been investigated as a potential herbicide and insecticide. The study of pelargonic acid is driven by its potential applications in various industries and its natural occurrence.'

pelargonic acid: K salt acts as cariostatic agent; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

nonanoic acid : A C9 straight-chain saturated fatty acid which occurs naturally as esters of the oil of pelargonium. Has antifungal properties, and is also used as a herbicide as well as in the preparation of plasticisers and lacquers. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8158
CHEMBL ID108436
CHEBI ID29019
SCHEMBL ID21966
MeSH IDM0052930

Synonyms (116)

Synonym
nsc-65455
nsc-65450
MLS001066339
smr000112203
pelargon
CHEBI:29019 ,
ch3-[ch2]7-cooh
pelargonsaeure
pergonic acid
nonansaeure
1-nonanoic acid
NCIOPEN2_000179
NCIOPEN2_000142
NCIOPEN2_001763
nsc 62787
fema no. 2784
1-octanecarboxyic acid
einecs 203-931-2
hsdb 5554
pelargon [russian]
brn 1752351
hexacid c-9
ai3-04164
epa pesticide chemical code 217500
n-nonylic acid
pelargic acid
nsc62787
cirrasol 185a
n-nonoic acid
1-octanecarboxylic acid
nonoic acid
nsc-62787
emfac 1202
wln: qv8
nonylic acid
n-nonanoic acid
inchi=1/c9h18o2/c1-2-3-4-5-6-7-8-9(10)11/h2-8h2,1h3,(h,10,11
nonanoic acid mfc9 h18 o2
pelargonic acid
C01601
112-05-0
nonanoic acid
nonanoic acid, >=97%
nonanoic acid, >=96%, fg
nonanoic acid, 96%
LMFA01010009
c9:0
NCGC00164328-01
NCIOPEN2_003483
NCIOPEN2_002882
68937-75-7
F57B4D17-8824-403B-AE1B-FA425608BB39
BMSE000499
CHEMBL108436
nonanoic acid anion
FT-0660055
P0952
N0288
fa 9:0
AKOS000118981
A802476
QSPL 030
NCGC00164328-03
NCGC00164328-02
dtxsid3021641 ,
NCGC00259975-01
dtxcid901641
tox21_300022
NCGC00253958-01
cas-112-05-0
tox21_202426
HMS2269L08
ec 273-086-2
einecs 273-086-2
unii-97seh7577t
ec 203-931-2
97seh7577t ,
4-02-00-01018 (beilstein handbook reference)
STL372710
KNA ,
3SZ1
S4949
pelargonic acid [mi]
nonanoic acid [hsdb]
nonanoic acid [fhfi]
nonanoic acid [fcc]
grantrico
thinex
pelargonic acid [inci]
BBL027459
SCHEMBL21966
emery 1202 (salt/mix)
emery 1203
octane-1-carboxylic acid
Q-201488
mfcd00004433
CCG-231471
nonanoic acid, analytical standard
nonanoic acid, natural, 98%, fg
emery 1202
emery's l-114
n-pelargonate
n-nonoate
n-nonylate
n-pelargonic acid
F0001-2447
Q369777
VS-08541
CS-0076036
BP-27910
HY-N7057
bdbm50556776
?nonanoic acid
EN300-19260
nonanoic acid, ?99%
Z104473336

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Pelargonic acid (31.25 mM) treatment of Salmonella cells resulted in a drop in culturable cells to below detection in an hour."( Susceptibility of Salmonella enterica Isolates from Tomato Farm Environments to Fatty Acids Naturally Found on Tomato Fruit.
Dev Kumar, G; Micallef, SA, 2017
)
1.18

Toxicity

ExcerptReferenceRelevance
" The Cosmetic Ingredient Review (CIR) Expert Panel concluded that these ingredients are safe in the present practices of use and concentration."( Final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of pelargonic acid (nonanoic acid) and nonanoate esters.
Andersen, FA; Belsito, DV; Bergfeld, WF; Heldreth, B; Hill, R; Johnson, W; Klaassen, CD; Liebler, D; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW, 2011
)
0.59
" Gallic acid was practically non-toxic (96-h lethal concentration (LC50) > 100 mg/L) whereas pelargonic acid was slightly toxic (96-h LC50 of 81."( Acute toxicity and sublethal effects of gallic and pelargonic acids on the zebrafish Danio rerio.
Fontaine, P; Milla, S; Techer, D; Thomas, M; Viot, S, 2015
)
0.89

Bioavailability

ExcerptReferenceRelevance
" Pelargonic, lauric, myristic, palmitic, margaric, stearic, and oleic acids were suspended in water dissolved in dimethyl sulfoxide (DMSO) or emulsified in water and quillaja saponin to assess how bioavailability impacted Salmonella growth."( Susceptibility of Salmonella enterica Isolates from Tomato Farm Environments to Fatty Acids Naturally Found on Tomato Fruit.
Dev Kumar, G; Micallef, SA, 2017
)
0.46

Dosage Studied

ExcerptRelevanceReference
" Smooth dose-response curves were obtained."( Skin irritancy from nonanoic acid.
Hietasalo, A; Wahlberg, JE; Wrangsjö, K, 1985
)
0.27
" Sodium lauryl sulfate (SLS) and non-anoic acid in different concentrations were applied daily to human and animal (rabbit and guinea pig) skin, and a dose-response relationship established."( Assessment of skin irritancy: measurement of skin fold thickness.
Wahlberg, JE, 1983
)
0.27
" Dose-response curves were obtained (concentrations 5, 10, 20 and 39."( Nonanoic acid irritation - a positive control at routine patch testing?
Maibach, HI; Wahlberg, JE, 1980
)
0.26
" Only glycerol showed dose-response and effects potentially better than no treatment."( Anti-irritants I: Dose-response in acute irritation.
Andersen, F; Andersen, KE; Bindslev-Jensen, C; Fullerton, A; Hedegaard, K; Petersen, TK, 2006
)
0.33
" The dose-response effect of 4 alleged AI (nifedipine, (-)-alpha-bisabolol, canola oil and glycerol) was studied on experimentally induced acute irritation in healthy volunteers, and only glycerol showed dose-related response and effects potentially better than no treatment."( Anti-irritants II: Efficacy against cumulative irritation.
Andersen, F; Andersen, KE; Bindslev-Jensen, C; Fullerton, A; Hedegaard, K; Petersen, TK, 2006
)
0.33
" A linear dose-response in RLU was observed with pure analyte."( Validation of the AccuPoint Advanced ATP Hygiene Monitoring System for Sanitation Monitoring Through Detection of ATP from Stainless Steel Surfaces.
Gray, RL; Mozola, M; Rice, J; Sarver, R; Steiner, B; Viator, R, 2017
)
0.46
" We tested the response of Lactuca sativa in complete dose-response experiments to six different toxicants at doses that did not decrease population mean and beyond."( Low doses of six toxicants change plant size distribution in dense populations of Lactuca sativa.
Belz, RG; Patama, M; Sinkkonen, A, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antifeedantA substance that prevents pests from feeding.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
Daphnia magna metaboliteA Daphnia metabolite produced by the species Daphnia magna.
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
straight-chain saturated fatty acidAny saturated fatty acid lacking a side-chain.
medium-chain fatty acidAny fatty acid with a chain length of between C6 and C12.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency3.07000.002541.796015,848.9004AID1347395
SMAD family member 2Homo sapiens (human)Potency46.30350.173734.304761.8120AID1346859; AID1346924
SMAD family member 3Homo sapiens (human)Potency46.30350.173734.304761.8120AID1346859; AID1346924
AR proteinHomo sapiens (human)Potency23.74690.000221.22318,912.5098AID743035; AID743036; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency47.03100.000657.913322,387.1992AID1259377
progesterone receptorHomo sapiens (human)Potency0.30640.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency52.76960.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency43.64120.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency44.75440.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency26.64960.000229.305416,493.5996AID743069; AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency4.74190.023723.228263.5986AID743223
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency25.11890.010039.53711,122.0200AID588545
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency89.12510.425612.059128.1838AID504891
gemininHomo sapiens (human)Potency14.95640.004611.374133.4983AID624296; AID624297
TAR DNA-binding protein 43Homo sapiens (human)Potency8.91251.778316.208135.4813AID652104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
G-protein coupled receptor 84Homo sapiens (human)EC50 (µMol)61.25000.08903.868710.0000AID1707044; AID1707045
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
biological_processG-protein coupled receptor 84Homo sapiens (human)
neuropeptide signaling pathwayG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
urotensin II receptor activityG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
plasma membraneG-protein coupled receptor 84Homo sapiens (human)
specific granule membraneG-protein coupled receptor 84Homo sapiens (human)
tertiary granule membraneG-protein coupled receptor 84Homo sapiens (human)
receptor complexG-protein coupled receptor 84Homo sapiens (human)
plasma membraneG-protein coupled receptor 84Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (27)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1081321Nematicidal activity against Bursaphelenchus xylophilus assessed as mortality at 0.125 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID1707045Agonist activity at human GPR84 expressed in CHO cell membranes assessed as induction of [35S]GTPgammaS incorporation incubated for 1 hr by liquid scintillation counting method2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists.
AID26261Partition coefficient (logD7.2)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1081322Nematicidal activity against Bursaphelenchus xylophilus assessed as mortality at 0.25 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID1707044Agonist activity at human GPR84 expressed in CHO cells assessed as reduction in forskolin-stimulated cAMP production preincubated for 20 mins followed by forskolin stimulation and measured after 20 mins by cAMP assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists.
AID25611Dissociation constant (pKa)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1112931Herbivore repellent activity against adult Arvicola amphibius assessed as time required to enter the test box with apple pieces for first time by T-maze test (Rvb = 380.25 +/-321.70 secs)2013Pest management science, Mar, Volume: 69, Issue:3
The repelling effect of plant secondary metabolites on water voles, Arvicola amphibius.
AID40936Inhibition of Bacillus subtilis PCI219 spore germination, expressed as log 1/I501982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID26793Partition coefficient (logP)1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID1112926Herbivore repellent activity against adult Arvicola amphibius assessed as duration of stay within test box with apple pieces by T-maze test (Rvb = 56.72 +/-13.89%)2013Pest management science, Mar, Volume: 69, Issue:3
The repelling effect of plant secondary metabolites on water voles, Arvicola amphibius.
AID1081320Nematicidal activity against Bursaphelenchus xylophilus assessed as mortality at 0.0625 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID40623Inhibitory activity on germination of Bacillus subtilis PCI219 spores was determined.1982Journal of medicinal chemistry, Mar, Volume: 25, Issue:3
Quantitative structure-inhibitory activity relationships of phenols and fatty acids for Bacillus subtilis spore germination.
AID40935Inhibition of Bacillus subtilis spore germination, activity is expressed as log of the reciprocal of Casida's I50 value.1983Journal of medicinal chemistry, Sep, Volume: 26, Issue:9
Ion-sensitive electrode potentiometry of organic anions: application to quantitative structure-activity relationships.
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2012Molecular pharmacology, Jun, Volume: 81, Issue:6
Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (134)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (17.91)18.7374
1990's19 (14.18)18.2507
2000's24 (17.91)29.6817
2010's51 (38.06)24.3611
2020's16 (11.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.77 (24.57)
Research Supply Index5.02 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index94.18 (26.88)
Search Engine Supply Index2.62 (0.95)

This Compound (46.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials12 (8.70%)5.53%
Reviews2 (1.45%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other124 (89.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]